Atrin Pharmaceuticals

About:

Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.

Website: http://www.atrinpharma.com/

Top Investors: National Cancer Institute, Ben Franklin Technology Partners of Southeastern Pennsylvania, Keiretsu Capital, Keiretsu Forum, Robin Hood Ventures

Description:

Atrin Pharmaceuticals is a privately held biopharmaceutical company, based in Doylestown, PA, that aims to change the way cancer is being treated. The company is engaged in the discovery and development of innovative treatments for cancer. The company's most advanced program is focused on a new class of compounds that are highly specific inhibitors of ATR, a key mediator of DNA repair. Atrin is further assembling a pipeline of additional drug candidates, identified via the company's proprietary, human cell-based, high-throughput screening platform, Atrize™. Applicable to both drug discovery/development and the evaluation of patient-specific treatments, Atrize enables the rapid identification and evaluation of compounds that are effective in inhibiting cancer cell viability without adversely affecting healthy cells.